Difference between revisions of "Ciprofloxacin (Cipro)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. | A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties. | ||
| − | [[Category: | + | ==Also known as== |
| + | *'''Brand name:''' Cipro | ||
| + | |||
| + | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| Line 7: | Line 10: | ||
[[Category:Fluoroquinolone]] | [[Category:Fluoroquinolone]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1987]] |
Latest revision as of 19:44, 30 July 2018
A fluoroquinolone antibiotic often used as prophylaxis during anticipated neutropenic nadirs. No known antineoplastic properties.
Also known as
- Brand name: Cipro